These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy. Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649 [TBL] [Abstract][Full Text] [Related]
26. The case for chemotherapy only for localized Hodgkin lymphoma. Straus DJ Oncologist; 2009 Dec; 14(12):1225-31. PubMed ID: 20007643 [TBL] [Abstract][Full Text] [Related]
27. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435 [TBL] [Abstract][Full Text] [Related]
28. Hodgkin lymphoma in Tyrol-a population-based study. Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373 [TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma. Finnegan V; Parsons JT; Greene BD; Sharma V Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443 [TBL] [Abstract][Full Text] [Related]
30. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006 [TBL] [Abstract][Full Text] [Related]
31. Radiotherapy of hodgkin lymphoma: indications, new fields, and techniques. Girinsky T; Ghalibafian M Semin Radiat Oncol; 2007 Jul; 17(3):206-22. PubMed ID: 17591568 [TBL] [Abstract][Full Text] [Related]
33. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II. Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149 [TBL] [Abstract][Full Text] [Related]
34. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491 [TBL] [Abstract][Full Text] [Related]
35. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk. Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522 [TBL] [Abstract][Full Text] [Related]
37. Re: Late effects from radiation therapy: the hits just keep on coming. Aleman BM; de Bruin ML; Dorresteijn LD; Krol AD; van 't Veer MB; Boogerd W; van Leeuwen FE J Natl Cancer Inst; 2010 Apr; 102(8):576-7; author reply 577-8. PubMed ID: 20308649 [No Abstract] [Full Text] [Related]
38. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects. Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328 [TBL] [Abstract][Full Text] [Related]
39. New strategies for the treatment of early stages of Hodgkin's lymphoma. Macdonald DA; Connors JM Hematol Oncol Clin North Am; 2007 Oct; 21(5):871-80. PubMed ID: 17908625 [TBL] [Abstract][Full Text] [Related]